Tevogen cuts liabilities to $14.8 million from $99.9 million
TVGN•Tevogen reduced liabilities to $14.8 million as of September 30, 2026, from $99.9 million at year-end 2023, and eliminated a further $7.6 million loan-related liability after the period-end.
1. Liabilities reduced
Tevogen said liabilities fell to $14.8 million as of September 30, 2026, from $99.9 million at year-end 2023. A further $7.6 million in liabilities related to a loan obligation was eliminated following the period-end.




